The global viral antigens market is witnessing robust expansion driven by increasing infectious disease prevalence, advancements in diagnostic testing, and heightened global health surveillance. Valued at USD 2.9 billion in 2025, the market is projected to reach USD 5.7 billion by 2035, recording an absolute increase of USD 2.8 billion over the forecast period. This reflects a...
English
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek